ALB ALBEMARLE CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 915913 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY24.4%
TTM net income YoY3,321.9%
TTM EPS YoY361.0%
Revenue 3-yr CAGR-14.6%
Net income 3-yr CAGR-41.0%
Margins
Gross margin25.8%
Operating margin10.0%
Net margin11.1%
FCF margin23.5%
EBITDA margin20.5%
Returns
ROE6.6%
ROA4.1%
ROIC (approx.)2.8%
Asset turnover0.37x
Leverage & solvency
Liabilities / assets32.7%
Debt / equity0.18x
Current ratio2.34x
Interest coverage4.13x
Cash quality & payout
Operating cash flow / net income2.71x
Accruals ratio-7.0%
Payout ratio28.0%
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.55B | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B | $1.08B | $1.23B |
| Cost of revenue | $1.25B | $1.15B | $927.76M | $1.23B | $1.19B | $1.13B | $920.58M | $1.09B |
| Gross profit | $300.72M | $590.30M | $500.97M | $197.93M | $117.61M | $196.88M | $156.30M | $138.21M |
| R&D expense | $8.17M | $3.67M | $9.17M | $12.18M | $12.67M | $12.44M | $14.10M | $20.02M |
| SG&A expense | $136.35M | $126.35M | $137.41M | $155.50M | $138.58M | $132.46M | $123.50M | $136.00M |
| Operating income | $148.16M | $452.94M | $233.51M | -$217.39M | -$216.99M | $47.53M | $19.76M | $4.40M |
| Interest expense | $27.80M | $30.92M | $33.12M | $57.78M | $50.96M | $49.94M | $48.98M | $44.70M |
| Pretax income | $133.22M | $441.65M | $254.19M | -$284.99M | -$239.15M | -$8.97M | -$18.97M | $76.73M |
| Income tax | $21.90M | $94.00M | $21.51M | $157.33M | -$30.57M | $34.09M | -$3.98M | $10.61M |
| Net income | $296.75M | $479.96M | $319.09M | -$414.18M | -$160.69M | $22.90M | $41.35M | $75.29M |
| EBITDA | $316.56M | $608.75M | $391.31M | -$53.68M | -$52.50M | $216.26M | $181.51M | $167.51M |
| EPS (basic) | 2.16 | 3.72 | 2.35 | — | -1.72 | -0.16 | 0.00 | — |
| EPS (diluted) | 2.15 | 3.52 | 2.34 | — | -1.72 | -0.16 | 0.00 | — |
| Dividends declared per share | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Weighted avg. shares (diluted) | 118.54M | 136.21M | 118.61M | — | 117.69M | 117.67M | 117.60M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.85B | $1.63B | $1.09B | $1.62B | $1.93B | $1.81B | $1.52B | $1.19B |
| Receivables | $606.38M | $603.80M | $522.72M | $593.50M | $733.48M | $766.43M | $670.77M | $742.20M |
| Inventory | $1.39B | $1.38B | $1.35B | $1.18B | $1.53B | $1.64B | $1.66B | $1.50B |
| Current assets | $4.23B | $3.94B | $3.26B | $4.01B | $4.55B | $4.51B | $4.11B | $3.84B |
| PP&E, net | $8.38B | $8.46B | $8.53B | $8.61B | $9.22B | $9.25B | $9.30B | $9.33B |
| Goodwill | $1.49B | $1.48B | $1.49B | $1.50B | $1.49B | $1.67B | $1.61B | $1.58B |
| Intangibles | $198.10M | $202.08M | $207.62M | $214.23M | $229.95M | $234.95M | $229.74M | $230.75M |
| Total assets | $16.08B | $15.91B | $15.14B | $16.37B | $17.15B | $17.29B | $17.00B | $16.61B |
| Current liabilities | $1.81B | $1.89B | $1.58B | $1.80B | $2.00B | $1.95B | $1.94B | $1.97B |
| Short-term debt | $74.60M | $74.68M | $74.63M | $74.08M | $445.38M | $444.91M | $410.48M | $398.02M |
| Long-term debt | $1.81B | $1.80B | $1.81B | $3.12B | $3.18B | $3.18B | $3.13B | $3.12B |
| Total debt | $1.88B | $1.88B | $1.88B | $3.19B | $3.63B | $3.62B | $3.54B | $3.52B |
| Total liabilities | $5.26B | $5.37B | $5.03B | $6.59B | $6.88B | $6.79B | $6.72B | $6.41B |
| Shareholders' equity | $10.54B | $10.28B | $9.85B | $9.53B | $10.00B | $10.24B | $10.03B | $9.96B |
| Net debt | $35.35M | $245.10M | $792.02M | $1.58B | $1.69B | $1.82B | $2.02B | $2.32B |
| Shares outstanding | 118.01M | 117.99M | 117.89M | 117.72M | 117.69M | 117.67M | 117.65M | 117.56M |
| Cash flow statement | ||||||||
| Operating cash flow | $405.80M | $710.00M | $346.24M | $388.49M | $355.60M | -$7.20M | $547.21M | -$4.38M |
| Capital expenditure | $80.37M | $71.73M | $98.68M | $155.38M | $132.16M | $119.63M | $182.62M | $342.81M |
| Free cash flow | $325.42M | $638.27M | $247.57M | $233.10M | $223.44M | -$126.83M | $364.58M | -$347.19M |
| Investing cash flow | -$85.57M | -$80.44M | $540.96M | -$176.64M | -$152.98M | $362.92M | -$129.06M | -$328.53M |
| Financing cash flow | -$109.46M | -$80.05M | -$1.41B | -$533.02M | -$90.53M | -$90.63M | -$120.01M | -$92.88M |
| Depreciation & amortization | $168.40M | $155.80M | $157.81M | $163.71M | $164.48M | $168.73M | $161.75M | $163.11M |
| Stock-based compensation | $9.56M | $6.78M | $7.88M | $12.22M | $10.98M | $10.10M | $6.97M | $7.70M |
| Dividends paid | $47.79M | $47.70M | $47.67M | $47.63M | $47.66M | $47.64M | $47.61M | $47.60M |
Free plan shows the latest 8 periods; Pro shows all 69 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.